[Parenteral chemotherapy with a trimethoprim-sulfamethoxazole combination in urology].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000008:administration & dosage*; D002908:Chronic Disease; D005260:Female; D005493:Folic Acid Antagonists / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy; D011743:Pyrimidines / Q000008:administration & dosage*; D013420:Sulfamethoxazole / Q000008:administration & dosage*; D013530:Surgical Wound Infection / Q000188:drug therapy; D014295:Trimethoprim / Q000008:administration & dosage; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control
D000892:Anti-Infective Agents, Urinary; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Parenterale Chemotherapie mit Trimethoprim plus Sulfamethoxazol in der Urologie.